NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson said Monday it has agreed to buy Aragon Pharmaceuticals Inc. for at least $650 million in cash, boosting its position in prostate drug development.

Johnson & Johnson, the world's biggest maker of health-care products, agreed to buy Aragon Pharmaceuticals Inc. and its experimental prostate cancer drug in a deal worth as much as $1 billion.

San Diego's Aragon Bought by Johnson & Johnson. advertisement. Click Here! Johnson & Johnson (J&J) will pay $650 million for San Diego-based Aragon Pharmaceuticals and its experimental prostate cancer drug.

Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million in cash upfront and a possible second payment of $350 million if it ...

The already-successful new prostate cancer drug Zytiga is not solely responsible for turning around the fortunes of Johnson & Johnson's (JNJ) once-lackluster drug business, but it has certainly played an important role. Johnson & Johnson is now ...

Ex-NFL star Chad Johnson was scolded for taking his domestic violence case lightly in court ... and now we have photos of his ex-wife Evelyn Lozada's face after the crime.

NEW BRUNSWICK, N.J., June 17, 2013 -- /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on ...

Johnson & Johnson announced it will buy San Diego-based Aragon Pharmaceuticals Inc. for up to $1 billion. The privately held Aragon will receive an initial payment of $650 million, and additional $350 million in milestone payments could follow from J&J ...

Speculative players have been taking sides on blue chip Johnson & Johnson (NYSE:JNJ), automaker General Motors Company (NYSE:GM), and Finnish telecom concern Nokia Corporation (ADR) (NYSE:NOK), according to data from the major options ...

This morning, Johnson & Johnson (JNJ) announced it would buy Aragon Pharmaceuticals for as much as $1 billion. Aragon Pharmaceuticals is a privately held company and as part of the deal would receive $650 million in cash upfront and an additional ...